Cargando…

Colorectal Cancer Screening With High Risk-Factor Questionnaire and Fecal Immunochemical Tests Among 5, 947, 986 Asymptomatic Population: A Population-Based Study

BACKGROUND: The recent uptrend in colorectal cancer (CRC) incidence in China is causing an increasingly overwhelming social burden. And its occurrence can be effectively reduced by sensitizing CRC screening for early diagnosis and treatment. However, a large number of people in China do not undergo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Mingqing, Zhao, Lizhong, Zhang, Yongdan, Jing, Haoren, Wei, Lianbo, Li, Zhixuan, Zhang, Haixiang, Zhang, Yong, Zhu, Siwei, Zhang, Shiwu, Zhang, Xipeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195590/
https://www.ncbi.nlm.nih.gov/pubmed/35712520
http://dx.doi.org/10.3389/fonc.2022.893183
_version_ 1784726998646521856
author Zhang, Mingqing
Zhao, Lizhong
Zhang, Yongdan
Jing, Haoren
Wei, Lianbo
Li, Zhixuan
Zhang, Haixiang
Zhang, Yong
Zhu, Siwei
Zhang, Shiwu
Zhang, Xipeng
author_facet Zhang, Mingqing
Zhao, Lizhong
Zhang, Yongdan
Jing, Haoren
Wei, Lianbo
Li, Zhixuan
Zhang, Haixiang
Zhang, Yong
Zhu, Siwei
Zhang, Shiwu
Zhang, Xipeng
author_sort Zhang, Mingqing
collection PubMed
description BACKGROUND: The recent uptrend in colorectal cancer (CRC) incidence in China is causing an increasingly overwhelming social burden. And its occurrence can be effectively reduced by sensitizing CRC screening for early diagnosis and treatment. However, a large number of people in China do not undergo screening due to multiple factors. To address this issue, since 2012, a CRC screening program has been initiated in Tianjin. METHODS: Residents aged 40-74 years were eligible for CRC screening. The first was to complete the high-risk factor questionnaire (HRFQ) and undergo fecal immunochemical test (FIT). Then those with a positive result in any of the two screening methods were recommended for a free colonoscopy. RESULTS: The detection rate of intestinal diseases increased with age, had a male predominance, and was higher in residents from central urban areas and those with primary school above education level. The sensitivity of predicting CRC after colonoscopy in the high-risk group was 76.02%; the specificity was 25.33%.A significant decrease in the detection rate of intestinal disease, CRC and advanced adenoma was observed from positive FIT, the high-risk group and positive HRFQ, 47.13%, 44.79%, 42.30%; 3.15%, 2.44%, 1.76%; 7.72%, 6.42%, 5.08%, in that order, while no inter-group difference was found for the detection of polyps. In addition, the different combinations of HRFQ and FIT can enroll more high-risk population than FIT or (and) HRFQ only, and thus detect more intestinal diseases (include CRC/AA/Polyp). CONCLUSION: The superimposition of different screening method for HRFQ and FIT is an effective strategy for the detection of CRC, AA, and Polyp, compared to HRFQ or FIT alone. However, further improvements in screening and interventions are needed to promote colonoscopy compliance.
format Online
Article
Text
id pubmed-9195590
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91955902022-06-15 Colorectal Cancer Screening With High Risk-Factor Questionnaire and Fecal Immunochemical Tests Among 5, 947, 986 Asymptomatic Population: A Population-Based Study Zhang, Mingqing Zhao, Lizhong Zhang, Yongdan Jing, Haoren Wei, Lianbo Li, Zhixuan Zhang, Haixiang Zhang, Yong Zhu, Siwei Zhang, Shiwu Zhang, Xipeng Front Oncol Oncology BACKGROUND: The recent uptrend in colorectal cancer (CRC) incidence in China is causing an increasingly overwhelming social burden. And its occurrence can be effectively reduced by sensitizing CRC screening for early diagnosis and treatment. However, a large number of people in China do not undergo screening due to multiple factors. To address this issue, since 2012, a CRC screening program has been initiated in Tianjin. METHODS: Residents aged 40-74 years were eligible for CRC screening. The first was to complete the high-risk factor questionnaire (HRFQ) and undergo fecal immunochemical test (FIT). Then those with a positive result in any of the two screening methods were recommended for a free colonoscopy. RESULTS: The detection rate of intestinal diseases increased with age, had a male predominance, and was higher in residents from central urban areas and those with primary school above education level. The sensitivity of predicting CRC after colonoscopy in the high-risk group was 76.02%; the specificity was 25.33%.A significant decrease in the detection rate of intestinal disease, CRC and advanced adenoma was observed from positive FIT, the high-risk group and positive HRFQ, 47.13%, 44.79%, 42.30%; 3.15%, 2.44%, 1.76%; 7.72%, 6.42%, 5.08%, in that order, while no inter-group difference was found for the detection of polyps. In addition, the different combinations of HRFQ and FIT can enroll more high-risk population than FIT or (and) HRFQ only, and thus detect more intestinal diseases (include CRC/AA/Polyp). CONCLUSION: The superimposition of different screening method for HRFQ and FIT is an effective strategy for the detection of CRC, AA, and Polyp, compared to HRFQ or FIT alone. However, further improvements in screening and interventions are needed to promote colonoscopy compliance. Frontiers Media S.A. 2022-05-30 /pmc/articles/PMC9195590/ /pubmed/35712520 http://dx.doi.org/10.3389/fonc.2022.893183 Text en Copyright © 2022 Zhang, Zhao, Zhang, Jing, Wei, Li, Zhang, Zhang, Zhu, Zhang and Zhang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zhang, Mingqing
Zhao, Lizhong
Zhang, Yongdan
Jing, Haoren
Wei, Lianbo
Li, Zhixuan
Zhang, Haixiang
Zhang, Yong
Zhu, Siwei
Zhang, Shiwu
Zhang, Xipeng
Colorectal Cancer Screening With High Risk-Factor Questionnaire and Fecal Immunochemical Tests Among 5, 947, 986 Asymptomatic Population: A Population-Based Study
title Colorectal Cancer Screening With High Risk-Factor Questionnaire and Fecal Immunochemical Tests Among 5, 947, 986 Asymptomatic Population: A Population-Based Study
title_full Colorectal Cancer Screening With High Risk-Factor Questionnaire and Fecal Immunochemical Tests Among 5, 947, 986 Asymptomatic Population: A Population-Based Study
title_fullStr Colorectal Cancer Screening With High Risk-Factor Questionnaire and Fecal Immunochemical Tests Among 5, 947, 986 Asymptomatic Population: A Population-Based Study
title_full_unstemmed Colorectal Cancer Screening With High Risk-Factor Questionnaire and Fecal Immunochemical Tests Among 5, 947, 986 Asymptomatic Population: A Population-Based Study
title_short Colorectal Cancer Screening With High Risk-Factor Questionnaire and Fecal Immunochemical Tests Among 5, 947, 986 Asymptomatic Population: A Population-Based Study
title_sort colorectal cancer screening with high risk-factor questionnaire and fecal immunochemical tests among 5, 947, 986 asymptomatic population: a population-based study
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195590/
https://www.ncbi.nlm.nih.gov/pubmed/35712520
http://dx.doi.org/10.3389/fonc.2022.893183
work_keys_str_mv AT zhangmingqing colorectalcancerscreeningwithhighriskfactorquestionnaireandfecalimmunochemicaltestsamong5947986asymptomaticpopulationapopulationbasedstudy
AT zhaolizhong colorectalcancerscreeningwithhighriskfactorquestionnaireandfecalimmunochemicaltestsamong5947986asymptomaticpopulationapopulationbasedstudy
AT zhangyongdan colorectalcancerscreeningwithhighriskfactorquestionnaireandfecalimmunochemicaltestsamong5947986asymptomaticpopulationapopulationbasedstudy
AT jinghaoren colorectalcancerscreeningwithhighriskfactorquestionnaireandfecalimmunochemicaltestsamong5947986asymptomaticpopulationapopulationbasedstudy
AT weilianbo colorectalcancerscreeningwithhighriskfactorquestionnaireandfecalimmunochemicaltestsamong5947986asymptomaticpopulationapopulationbasedstudy
AT lizhixuan colorectalcancerscreeningwithhighriskfactorquestionnaireandfecalimmunochemicaltestsamong5947986asymptomaticpopulationapopulationbasedstudy
AT zhanghaixiang colorectalcancerscreeningwithhighriskfactorquestionnaireandfecalimmunochemicaltestsamong5947986asymptomaticpopulationapopulationbasedstudy
AT zhangyong colorectalcancerscreeningwithhighriskfactorquestionnaireandfecalimmunochemicaltestsamong5947986asymptomaticpopulationapopulationbasedstudy
AT zhusiwei colorectalcancerscreeningwithhighriskfactorquestionnaireandfecalimmunochemicaltestsamong5947986asymptomaticpopulationapopulationbasedstudy
AT zhangshiwu colorectalcancerscreeningwithhighriskfactorquestionnaireandfecalimmunochemicaltestsamong5947986asymptomaticpopulationapopulationbasedstudy
AT zhangxipeng colorectalcancerscreeningwithhighriskfactorquestionnaireandfecalimmunochemicaltestsamong5947986asymptomaticpopulationapopulationbasedstudy